277 related articles for article (PubMed ID: 25678488)
21. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
[TBL] [Abstract][Full Text] [Related]
22. Coupled Imaging with [
Chiaravalloti A; Castellano AE; Ricci M; Barbagallo G; Sannino P; Ursini F; Karalis G; Schillaci O
Mol Imaging Biol; 2018 Aug; 20(4):659-666. PubMed ID: 29404839
[TBL] [Abstract][Full Text] [Related]
23. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
[TBL] [Abstract][Full Text] [Related]
24. Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data.
Aalto S; Scheinin NM; Kemppainen NM; Någren K; Kailajärvi M; Leinonen M; Scheinin M; Rinne JO
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1651-60. PubMed ID: 19495749
[TBL] [Abstract][Full Text] [Related]
25. Alzheimer Disease and Mild Cognitive Impairment: Integrated Pulsed Arterial Spin-Labeling MRI and
Riederer I; Bohn KP; Preibisch C; Wiedemann E; Zimmer C; Alexopoulos P; Förster S
Radiology; 2018 Jul; 288(1):198-206. PubMed ID: 29762090
[TBL] [Abstract][Full Text] [Related]
26. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
27. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.
Kemppainen NM; Aalto S; Wilson IA; Någren K; Helin S; Brück A; Oikonen V; Kailajärvi M; Scheinin M; Viitanen M; Parkkola R; Rinne JO
Neurology; 2006 Nov; 67(9):1575-80. PubMed ID: 16971697
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity.
Marchitelli R; Aiello M; Cachia A; Quarantelli M; Cavaliere C; Postiglione A; Tedeschi G; Montella P; Milan G; Salvatore M; Salvatore E; Baron JC; Pappatà S
Neuroimage; 2018 Aug; 176():246-258. PubMed ID: 29709628
[TBL] [Abstract][Full Text] [Related]
29. Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.
Ossenkoppele R; van der Flier WM; Verfaillie SC; Vrenken H; Versteeg A; van Schijndel RA; Sikkes SA; Twisk J; Adriaanse SM; Zwan MD; Boellaard R; Windhorst AD; Barkhof F; Scheltens P; Lammertsma AA; van Berckel BN
Neurology; 2014 May; 82(20):1768-75. PubMed ID: 24748672
[TBL] [Abstract][Full Text] [Related]
30. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
Lehmann M; Ghosh PM; Madison C; Laforce R; Corbetta-Rastelli C; Weiner MW; Greicius MD; Seeley WW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2013 Mar; 136(Pt 3):844-58. PubMed ID: 23358601
[TBL] [Abstract][Full Text] [Related]
31. Association of hypometabolism and amyloid levels in aging, normal subjects.
Lowe VJ; Weigand SD; Senjem ML; Vemuri P; Jordan L; Kantarci K; Boeve B; Jack CR; Knopman D; Petersen RC
Neurology; 2014 Jun; 82(22):1959-67. PubMed ID: 24793183
[TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
[TBL] [Abstract][Full Text] [Related]
33. The Association of Glucose Metabolism and Eigenvector Centrality in Alzheimer's Disease.
Adriaanse SM; Wink AM; Tijms BM; Ossenkoppele R; Verfaillie SC; Lammertsma AA; Boellaard R; Scheltens P; van Berckel BN; Barkhof F
Brain Connect; 2016 Feb; 6(1):1-8. PubMed ID: 26414628
[TBL] [Abstract][Full Text] [Related]
34. Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.
Lao PJ; Handen BL; Betthauser TJ; Mihaila I; Hartley SL; Cohen AD; Tudorascu DL; Bulova PD; Lopresti BJ; Tumuluru RV; Murali D; Mathis CA; Barnhart TE; Stone CK; Price JC; Devenny DA; Johnson SC; Klunk WE; Christian BT
J Alzheimers Dis; 2018; 61(2):631-644. PubMed ID: 29254096
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
Fan Z; Okello AA; Brooks DJ; Edison P
Brain; 2015 Dec; 138(Pt 12):3685-98. PubMed ID: 26510952
[TBL] [Abstract][Full Text] [Related]
36. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.
Rabinovici GD; Furst AJ; O'Neil JP; Racine CA; Mormino EC; Baker SL; Chetty S; Patel P; Pagliaro TA; Klunk WE; Mathis CA; Rosen HJ; Miller BL; Jagust WJ
Neurology; 2007 Apr; 68(15):1205-12. PubMed ID: 17420404
[TBL] [Abstract][Full Text] [Related]
37. The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease.
Adriaanse SM; van Dijk KR; Ossenkoppele R; Reuter M; Tolboom N; Zwan MD; Yaqub M; Boellaard R; Windhorst AD; van der Flier WM; Scheltens P; Lammertsma AA; Barkhof F; van Berckel BN
Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1190-8. PubMed ID: 24615466
[TBL] [Abstract][Full Text] [Related]
38. White matter hyperintensities predict amyloid increase in Alzheimer's disease.
Grimmer T; Faust M; Auer F; Alexopoulos P; Förstl H; Henriksen G; Perneczky R; Sorg C; Yousefi BH; Drzezga A; Kurz A
Neurobiol Aging; 2012 Dec; 33(12):2766-73. PubMed ID: 22410648
[TBL] [Abstract][Full Text] [Related]
39. 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias.
Taswell C; Villemagne VL; Yates P; Shimada H; Leyton CE; Ballard KJ; Piguet O; Burrell JR; Hodges JR; Rowe CC
J Nucl Med; 2015 Oct; 56(10):1547-53. PubMed ID: 26251415
[TBL] [Abstract][Full Text] [Related]
40. Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients.
Rostomian AH; Madison C; Rabinovici GD; Jagust WJ
J Nucl Med; 2011 Feb; 52(2):173-9. PubMed ID: 21233181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
